20 (AIDX) Intangibles (2024 - 2026)

20 (AIDX) posted Intangibles of $206801.0 for Q1 2026, up 2.24% on a QoQ basis from $202264.0 in Q4 2025.

20 (AIDX) Intangibles (2024 - 2026) Analysis & Trends

20's Intangibles history runs 3 years deep, the most recent figure standing at $206801.0 for Q1 2026.

Quarterly Intangibles changed N/A year-over-year to $206801.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $206801.0 (changed N/A YoY) and the FY2025 annual result came in at $202264.0, down 1.59% from the prior year.
Intangibles was $206801.0 for Q1 2026 at 20, up from $202264.0 in the prior quarter.
Across five years, Intangibles topped out at $206801.0 in Q1 2026 and bottomed at $202264.0 in Q4 2025.
A 3-year average of $204864.7 and a median of $205529.0 in 2024 frame the typical range for Intangibles.
Peak annual rise in Intangibles reached 1.59% in 2025, while the deepest fall reached 1.59% in 2025.
20's Intangibles stood at $205529.0 in 2024, then decreased by 1.59% to $202264.0 in 2025, then gained by 2.24% to $206801.0 in 2026.
Business Quant data shows AIDX's Intangibles at $206801.0 in Q1 2026, $202264.0 in Q4 2025, and $205529.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	17.88 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	5.52 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	10.15 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	7.06 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	1.23 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	62.60 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	3.14 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	1.91 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	882.00 Mn
10	20	3.91 Mn	-313,912.28	62,884.00	206,801.00

Download Data